Clinical Trial Update: Long-Term Treatment Effect With Tildrakizumab in Participants With Plaque Psoriasis [Phase 4]

View source ↗

Summary

Phase 4 trial update on long-term treatment effect of tildrakizumab in participants with plaque psoriasis; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Tildrakizumab (tildrakizumab)

Snippet

Sponsor: Almirall, S.A. | Conditions: Plaque Psoriasis | Phase 4 | Status: TERMINATED